Elevated levels of FOSL1 are a significant predictor of poor prognosis in HCC patients and serve as an independent risk factor, suggesting that detecting FOSL1 ectopic expression can help identify high-risk patients, and targeting FOSL1 could be a viable therapeutic strategy for HCC treatment [104]. Here, FOSL1 is linked to hepatocellular carcinoma.